Hjem › Kreft (alle typer) › California › Baldwin Park
Kliniske studier for Kreft (alle typer) i Baldwin Park, CA
34 studier for Kreft (alle typer) søker deltakere på steder i og rundt Baldwin Park (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
RekruttererFase 3
- City of Hope /ID# 243157, Duarte · 4 mi unna
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
RekruttererFase 2/3
- City of Hope National Medical Center /ID# 277005, Duarte · 4 mi unna
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
RekruttererFase 2/3
- City of Hope National Medical Center /ID# 282241, Duarte · 4 mi unna
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
RekruttererFase 1/2
- City of Hope Duarte, Duarte · 4 mi unna
A Study of ASP3082 in Adults With Advanced Solid Tumors
RekruttererFase 1
- City of Hope National Medical Center, Duarte · 4 mi unna
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RekruttererFase 1
- City of Hope, Duarte · 4 mi unna
A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
RekruttererFase 2
- City Of Hope Comprehensive Cancer Center /ID# 281939, Duarte · 4 mi unna
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
RekruttererFase 1
- City of Hope National Medical Center /ID# 280273, Duarte · 4 mi unna
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
RekruttererFase 1
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi unna
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
RekruttererFase 1
- City of Hope, Duarte · 4 mi unna
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
RekruttererFase 3
- Quetzal Site 1, Duarte · 4 mi unna
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
RekruttererFase 3
- City of Hope National Medical Center /ID# 281322, Duarte · 4 mi unna
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
RekruttererFase 2/3
- City Of Hope, Duarte · 4 mi unna
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
RekruttererFase 2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi unna
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
RekruttererFase 3
- Research Site, Duarte · 4 mi unna
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
RekruttererObservasjonsstudie
- City of Hope, Duarte · 4 mi unna
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
RekruttererFase 1
- City of Hope, Duarte · 4 mi unna
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
RekruttererFase 1
- City of Hope Duarte, Duarte · 4 mi unna
Project: Every Child for Younger Patients With Cancer
RekruttererObservasjonsstudie
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi unna
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
RekruttererFase 1/2
- City of Hope, Duarte · 4 mi unna
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RekruttererFase 1/2
- City of Hope, Duarte · 4 mi unna
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
RekruttererFase 1/2
- City of Hope National Medical Center /ID# 273132, Duarte · 4 mi unna
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
RekruttererFase 1
- City of Hope, Duarte · 4 mi unna
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
RekruttererFase 1/2
- City of Hope - Duarte, Duarte · 4 mi unna
Molecular Genetics Studies of Cancer Patients and Their Relatives
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- City of Hope Medical Center, Duarte · 4 mi unna
Childhood Cancer Survivor Study
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- City of Hope National Medical Center, Duarte · 4 mi unna
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
RekruttererFase 1
- The City of Hope National Medical Center, Duarte · 4 mi unna
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RekruttererFase 2
- City of Hope, Duarte · 4 mi unna
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Rekrutterer
- Beckman Research Institute of City of Hope, Duarte · 4 mi unna
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RekruttererFase 1/2
- City of Hope, Duarte · 4 mi unna
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
RekruttererFase 3
- City of Hope, Duarte · 4 mi unna
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Duarte · 4 mi unna
Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
RekruttererObservasjonsstudie
- City Of Hope, Duarte · 4 mi unna
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
RekruttererFase 3
- City of Hope National Medical Center, Duarte · 4 mi unna
Kreft (alle typer)-studier i andre byer
- Houston, TX121 studier
- New York City, NY109 studier
- Boston, MA85 studier
- Los Angeles, CA74 studier
- Nashville, TN65 studier
- Philadelphia, PA59 studier
- Washington, DC58 studier
- Durham, NC58 studier
- Chicago, IL51 studier
- Atlanta, GA49 studier
- Seattle, WA49 studier
- Arlington, VA48 studier
Andre studier i Baldwin Park
- Brystkreft44 studier
- Akut myelogen leukemi40 studier
- Kolorektal kreft37 studier
- Ikke-småcellet lungekreft36 studier
- Prostatakreft30 studier
- Metastatisk kreft30 studier
- Myelodysplastiske syndromer26 studier
- Eggstokkreft25 studier
- Lungekreft24 studier
- Multipelt myelom23 studier
- Mavekreft22 studier
- Akut lymfoblastisk leukemi21 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.